2-propanol has been researched along with Bacteremia in 15 studies
2-Propanol: An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.
propan-2-ol : A secondary alcohol that is propane in which one of the hydrogens attached to the central carbon is substituted by a hydroxy group.
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Shaheen, N | 1 |
| Zeeshan, M | 1 |
| Fasih, N | 1 |
| Farooqi, J | 1 |
| Jabeen, K | 1 |
| Irfan, S | 1 |
| Brunelli, SM | 1 |
| Van Wyck, DB | 1 |
| Njord, L | 1 |
| Ziebol, RJ | 1 |
| Lynch, LE | 1 |
| Killion, DP | 1 |
| Maunoury, F | 1 |
| Farinetto, C | 1 |
| Ruckly, S | 1 |
| Guenezan, J | 1 |
| Lucet, JC | 1 |
| Lepape, A | 1 |
| Pascal, J | 1 |
| Souweine, B | 1 |
| Mimoz, O | 1 |
| Timsit, JF | 1 |
| Yodoshi, T | 1 |
| Ueda, S | 1 |
| Goldman, RD | 1 |
| Ausserhofer, D | 1 |
| Fritz, E | 1 |
| Them, C | 1 |
| McDonald, C | 1 |
| McGuane, S | 1 |
| Thomas, J | 1 |
| Hartley, S | 2 |
| Robbins, S | 2 |
| Roy, A | 3 |
| Verlander, N | 2 |
| Barbara, J | 1 |
| Dettenkofer, M | 1 |
| Wilson, C | 1 |
| Gratwohl, A | 1 |
| Schmoor, C | 1 |
| Bertz, H | 1 |
| Frei, R | 1 |
| Heim, D | 1 |
| Luft, D | 1 |
| Schulz, S | 1 |
| Widmer, AF | 1 |
| Ramirez-Arcos, S | 1 |
| Goldman, M | 1 |
| Sannoh, S | 1 |
| Clones, B | 1 |
| Munoz, J | 1 |
| Montecalvo, M | 1 |
| Parvez, B | 1 |
| Lockman, JL | 1 |
| Heitmiller, ES | 1 |
| Ascenzi, JA | 1 |
| Berkowitz, I | 1 |
| McDonald, CP | 2 |
| Mahajan, P | 1 |
| Smith, R | 1 |
| Charlett, A | 1 |
| Barbara, JA | 2 |
| Brayer, C | 1 |
| Micheau, P | 1 |
| Bony, C | 1 |
| Tauzin, L | 1 |
| Pilorget, H | 1 |
| Sampériz, S | 1 |
| Alessandri, JL | 1 |
| Lowe, P | 1 |
| Harrison, JF | 1 |
| Slopecki, A | 1 |
| Chen, X | 1 |
| Baumal, CR | 1 |
| Kennedy, CJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap[NCT02593149] | 1,902 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
| [NCT01629550] | Phase 4 | 2,400 participants | Interventional | 2012-10-31 | Completed | ||
| Skin Disinfection With Octenidine Dihydrochloride for the Prevention of Catheter-Associated Infections - A Double-Blind, Randomized, Controlled Trial[NCT00515151] | Phase 4 | 400 participants (Actual) | Interventional | 2002-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"This was calculated by dividing the cumulative number of PBCs by cumulative time at-risk as follows.~The National Healthcare Safety Network (NHSN) Center for Disease Control (CDC) 21-day outpatient hemodialysis patient rule is as follows: A PBC is considered a new event and counted only if it occurred 21 days or more after a previously reported PBC in the same patient; new PBC events are based on blood cultures drawn as an outpatient or within one calendar day after a hospital admission. Following a PBC additional same-type events were counted beginning 21 days following the initial event; the CVC-days were counted during this period. The CVC-days were calculated by summing the number of days each patient was at-risk of accruing a PBC. This analysis included all subjects that participated in the study that were not otherwise censored to more accurately count CVC-days." (NCT02593149)
Timeframe: Through the 13-month intervention period.
| Intervention | PBCs per 1,000 CVC-days (Number) |
|---|---|
| Treatment | 0.28 |
| Control | 0.75 |
1 review available for 2-propanol and Bacteremia
| Article | Year |
|---|---|
[Care of the non-tunneled central venous catheter. Literature search on disinfectants, dressings and intervals between dressing changes].
Topics: 2-Propanol; Bacteremia; Bacterial Infections; Bandages; Catheterization, Central Venous; Chlorhexidi | 2008 |
5 trials available for 2-propanol and Bacteremia
| Article | Year |
|---|---|
Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection.
Topics: 2-Propanol; Aged; Antibiotic Prophylaxis; Bacteremia; Catheter-Related Infections; Central Venous Ca | 2018 |
Cost-effectiveness analysis of chlorhexidine-alcohol versus povidone iodine-alcohol solution in the prevention of intravascular-catheter-related bloodstream infections in France.
Topics: 2-Propanol; Alcohols; Bacteremia; Catheter-Related Infections; Chlorhexidine; Cost-Benefit Analysis; | 2018 |
A novel rapid and effective donor arm disinfection method.
Topics: 2-Propanol; Anti-Infective Agents, Local; Bacteremia; Bacteria; Benchmarking; Blood Banking; Blood B | 2010 |
Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial.
Topics: 2-Propanol; Aged; Anti-Infective Agents, Local; Bacteremia; Catheter-Related Infections; Catheteriza | 2010 |
Skin disinfection methods: prospective evaluation and postimplementation results.
Topics: 2-Propanol; Anti-Infective Agents, Local; Bacteremia; Bacteria; Blood Banking; Blood Banks; Blood Do | 2010 |
9 other studies available for 2-propanol and Bacteremia
| Article | Year |
|---|---|
Efforts to improve diagnosis of bacteraemia by reducing blood culture contamination in an emergency department: strategies and outcome.
Topics: 2-Propanol; Anti-Infective Agents, Local; Bacteremia; Blood Culture; Blood Specimen Collection; Chlo | 2020 |
Skin preparation for prevention of peripheral blood culture contamination in children.
Topics: 2-Propanol; Anti-Infective Agents, Local; Antisepsis; Bacteremia; Blood Culture; Child; Child, Presc | 2019 |
A multimodal approach to central venous catheter hub care can decrease catheter-related bloodstream infection.
Topics: 2-Propanol; Bacteremia; Catheter-Related Infections; Catheters, Indwelling; Chlorhexidine; Disinfect | 2010 |
Scrub the hub! Catheter needleless port decontamination.
Topics: 2-Propanol; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Cross Infectio | 2011 |
Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion.
Topics: 2-Propanol; Arm; Bacteremia; Bacteriological Techniques; Blood; Blood Donors; Blood Specimen Collect | 2004 |
[Neonatal accidental burn by isopropyl alcohol].
Topics: 2-Propanol; Accidents, Home; Bacteremia; Burns, Chemical; Enterococcus faecalis; Fatal Outcome; Gram | 2004 |
Evaluation of donor arm disinfection techniques.
Topics: 2-Propanol; Administration, Cutaneous; Arm; Bacteremia; Bacteria; Bacteriological Techniques; Blood | 2001 |
Iris Abscess.
Topics: Abscess; Adult; Bacteremia; Female; Humans; Iris; Iris Diseases; Staphylococcal Infections; Tomograp | 2018 |
Sectorial iris infarction caused by meningococcal septicaemia.
Topics: Anti-Bacterial Agents; Bacteremia; Conjunctival Diseases; Disseminated Intravascular Coagulation; Ey | 1995 |